The Long Run with Luke Timmerman
A podcast by Timmerman Report

173 Episodes
-
Ep135: John Maraganore on Developing a New Class of Medicines
Published: 5/8/2023 -
Ep134: Emile Nuwaysir on In Vivo Gene Editing Therapies
Published: 4/24/2023 -
Ep133: Catherine Stehman-Breen on Epigenetic Editing Therapies
Published: 4/12/2023 -
Ep132: Eric Dobmeier on Treating Kidney Disease
Published: 3/28/2023 -
Ep131: Ryan Watts on Neuroscience Drug R&D
Published: 3/14/2023 -
Ep130: David Hallal on a Life in Biotech & the Cell Therapy Wave
Published: 2/28/2023 -
Ep129: Joanne Smith-Farrell on Engineered B-Cell Therapies
Published: 2/14/2023 -
Ep128: Rick Berke on Building a Biotech Journalism Outlet to Last
Published: 2/1/2023 -
Ep127: Jeb Keiper on Computational Drug Discovery
Published: 1/20/2023 -
Ep126: DA Wallach on Becoming a Biotech VC
Published: 1/3/2023 -
Ep125: Barry Greene on a New Drug for Depression
Published: 12/19/2022 -
Ep124: Shehnaaz Suliman on Delivery of Genetic Medicines
Published: 11/8/2022 -
Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery
Published: 10/27/2022 -
Ep122: Aetna Wun Trombley on Extracellular Protein Degraders
Published: 10/11/2022 -
Ep121: Samantha Truex on Going Upstream Against Severe Asthma
Published: 9/26/2022 -
Ep120: Tim Lu on Gene Circuits for Cell Therapy
Published: 9/7/2022 -
Ep119: Jo Viney on Discovering Treatments for Autoimmune Disease
Published: 8/22/2022 -
Ep118: Ivan Liachko on Assembling Accurate Genomes and Interactomes
Published: 8/8/2022 -
Ep117: Dr. Sanduk Ruit on Restoring Eyesight in the Developing World
Published: 7/11/2022 -
Ep116: Ivana Magovcevic-Liebisch on Precision Neuroscience
Published: 6/22/2022
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.